Growth before and during growth hormone treatment in children operated for craniopharyngioma

Hormone Research in Paediatrics

Volumn 48, Issue 6, 1997, Pages 258-262

  Hogeveen, Marije ^a   Noordam, Cees ^b   Otten, Bartho ^b   Wit, Jan Maarten ^a   Massa, Guy ^a,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c Bur of the Dutch Growth Foundation   (Netherlands)

Author keywords

Body mass index; Craniopharyngioma; Growth; Growth hormone; Prolactin

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BODY GROWTH; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DRUG EFFICACY; FEMALE; GROWTH RETARDATION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0030726734     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185531     Document Type: Article

References (20)

1. Curtis J, Daneman D, Hoffman HJ, Ehrlich RM: The endocrine outcome after surgical removal of craniopharyngiomas. Pcdiatr Ncuro-surg 1994:21(suppl l):24-27.
2. Sklar CA: Craniopharyngioma: Endocrine abnormalities at presentation. Pediatr Neurosurg 1994;2l(suppl 1): 18-20.
3. Jenkins JS. Gilbert CJ, Ang V: Hypothalamic-pituitary function in patients with craniopharyngiomas. J Clin Endocrinol Metab 1976:43: 394-399.
4. Thomsett MJ, Conte FA, Kaplan SL, Grom-bach MM: Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients. J Pediatr 1983; 97:728-735.
5. Blethen SL, Weldon VV: Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sei 1986:229: 21-24.
6. Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R: Insulin-like growth factors I and II. prolactin, and insulin in 19 growth-hormone deficient children with excessive, normal or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 1983;309:1142-1146.
7. Frasier SD, Smith FG: Return of normal growth following removal of a craniopharyngioma. Am J Dis Child 1968;116:311-314.
8. Stahnkc N, Grubcl G, Lagenstein I, Willig RP: Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984; 142:179-185.
9. Holmes LB, Frantz AG, Rabkin MT. Soeldner JS, Crawford JD: Normal growth with subnormal growth-hormone levels. N Engl J Med 1968;279:559-566.
10. Costin G, Kogut MD, Philips A, Daughadav WH: Craniopharyngioma: The role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 1976:42:370-379.
11. Kenny FM, Guyda HJ, Wright JC: Prolactin and somatomedin in hvpopituitary patients with 'catch-up' growth following operations for craniopharyngioma. J Clin Endocrinol Metab 1973;36:378-380.
12. Rikken B, Massa GG, Wit JM. The Dutch Growth Hormone Working Group: Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone. Horm Res 1995:43:135-137.
13. Roede MJ, van Wieringen JC: Growth diagrams 1980: Netherlands Third Nation wide Survey. Tijdschr Soc Gczondheidszorg 1985; 63(suppl): 1-34.
14. Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, van den Brande JL: Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr 1988:147: 658-661.
15. Sorva R: Growth in children with craniopharyngioma. Acta Paediatr Scand 1988:77:587-592.
16. De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R: Obesity in childhood craniopharyngioma: Relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996;81:2734-2737.
17. Finkclstein JW, Kream J, Ludan A, Heilman L: Sulfation factor (somatomedin): An explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors. J Clin Endocrinol Metab 1972:35:13-17.
18. Schocnle EJ, Zapf J, Prader A, Torresani T, Werecr EA, Zachmann M: Replacement of growth-hormone (GH) in normally growing GH-deficicnt patients operated for craniopha-rvngioma. J Clin Endocrinol Metab 1995:80: 374-378.
19. Price DA: Characteristics and first year response to growth-hormone of children with craniopharyngioma. Biannual Report KJGS 1992;5:25-38.
20. Van Vliet G, Bosson D, Craen M, Du Caju MVL, Malvaux P, Vanderschucren-Lode-weyckx M: Comparative study of the lipolytic potencies of pituitary-derived and biosynthetic human growth hormone in hvpopituitary children. J Clin Endocrinol Metab 1987;65:876-879.